RTTNews | Oct 8, 2020 10:19PM EDT

22:19 Thursday, October 8, 2020 (RTTNews.com) - Danish pharmaceutical company Novo Nordisk A/S (NVO) said that it raised its full-year sales and operating profit outlook at constant exchange rates.

For 2020, the company now expects both operating profit and sales growth to be 5%-8% at constant exchange rates. Earlier, the company expected annual operating profit growth to be 2% to 5%, and sales growth of 3% to 6% at CER.

In the third quarter of 2020, the company's sales increased by 7% and operating profit increased by 7%, both at constant exchange rates, reflecting lower than anticipated negative impacts from COVID-19 as well as underlying market demand. Sales growth was positively impacted by inventory changes at wholesaler level in the US.

Read the original article on RTTNews ( https://www.rttnews.com/3134967/novo-nordisk-raises-fy-outlook.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved